连续自动气管导管套囊压力监测预防儿科重症监护病房呼吸机相关性肺炎的有效性:一项随机对照试验
该开放标签随机对照优效性试验纳入241例需机械通气≥48小时的儿科患者,比较连续自动套囊压力监测(CACPM)与间歇手动监测(IMCPM)对呼吸机相关性肺炎(VAP)的影响。意向性分析显示CACPM组VAP发生率显著低于IMCPM组(13.3% vs 24.0%;风险差-10.6个百分点;95%CI -20.3至-0.8;P=0.034),且CACPM组目标压力依从性更高(P<0.001)。
要点
- CACPM可降低儿科重症患者28天内VAP发生率(13.3% vs 24.0%,P=0.034)。
- CACPM组目标套囊压力(20-25 cmH2O)依从性显著更高(P<0.001)。
- 调整后Cox分析显示IMCPM组VAP风险更高(HR 1.90;95%CI 1.024-3.510;P=0.042)。
核心结论
- 与间歇手动套囊压力监测相比,连续自动套囊压力监测显著降低危重儿科患者VAP的发生比例。
- 该预防效果似乎直接与目标压力依从性改善相关,自动化调节可能成为儿科VAP预防策略的有价值补充。
研究设计与样本
- 开放标签、随机对照优效性试验,纳入需机械通气≥48小时的儿科患者,按1:1随机分配至CACPM组或IMCPM组。
- 共随机分配241例患者,主要结局为插管后28天内发生VAP的患者比例,在意向性治疗人群中评估。
- 目标套囊压力严格维持在20-25 cmH2O;采用Kaplan-Meier生存分析和多因素Cox比例风险回归进行统计分析。
主要发现
- 意向性分析显示CACPM组VAP发生率低于IMCPM组(13.3% vs 24.0%;风险差-10.6个百分点;95%CI -20.3至-0.8;P=0.034)。
- 符合方案分析结果相似(15.0% vs 26.6%;P=0.044)。
- 意向性分析 incidence density 为15.7 vs 27.1/1000机械通气日(IRR 1.73;95%CI 0.94-3.18;P=0.080)。
- 未调整的至VAP时间分析无统计学意义(HR 1.80;95%CI 0.976-3.321;P=0.060),调整后Cox分析显示IMCPM组VAP风险更高(HR 1.90;95%CI 1.024-3.510;P=0.042)。
- CACPM组目标压力依从性更高(P<0.001)。
关键数值与推荐
- 目标套囊压力严格维持在20-25 cmH2O。
- 主要结局为插管后28天内VAP发生率,在意向性治疗人群中评估。
临床怎么用
- 在儿科重症监护病房中,对机械通气患儿可采用连续自动套囊压力监测以维持目标压力并降低VAP发生比例。
- 需注意该研究为开放标签设计,且部分次要结局指标(如 incidence density 和未调整时间-事件分析)未达统计学显著性。
局限性
- 开放标签设计可能引入实施偏倚。
- incidence density 和未调整时间至VAP分析未显示统计学显著性,需谨慎解读次要结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventilator-associated pneumonia (VAP) is a major healthcare-associated infection in critically ill children, primarily driven by microaspiration around the endotracheal tube cuff. RESEARCH QUESTION: Does continuous automatic cuff pressure monitoring (CACPM) reduce the incidence of VAP compared to intermittent manual cuff pressure monitoring (IMCPM) in critically ill pediatric patients requiring mechanical ventilation? STUDY DESIGN AND METHODS: In this open-label, randomized controlled superiority trial, pediatric patients requiring mechanical ventilation for ≥48 hours were randomly assigned (1:1) to either CACPM or IMCPM. The target cuff pressure was strictly maintained at 20-25 cmH2O. The primary outcome was the proportion of patients developing VAP within 28 days following intubation, evaluated in the intention to treat population. Secondary outcomes included time to VAP diagnosis and target pressure compliance. Statistical approaches included Kaplan-Meier survival analysis and multivariable Cox proportional hazard regression. RESULTS: Among 241 randomized patients, ITT analysis showed lower VAP with CACPM than IMCPM (13.3% vs 24.0%; risk difference, -10.6 percentage points; 95% CI, -20.3 to -0.8; P=0.034), with similar PP findings (15.0% vs 26.6%; P=0.044). ITT incidence density was 15.7 vs 27.1 per 1,000 ventilator-days (IRR, 1.73; 95% CI, 0.94-3.18; P=0.080). Unadjusted time-to-VAP was nonsignificant (HR, 1.80; 95% CI, 0.976-3.321; P=0.060), whereas adjusted Cox analysis narrowly indicated a higher VAP hazard with IMCPM (HR, 1.90; 95% CI, 1.024-3.510; P=0.042). Target-pressure compliance was higher with CACPM (P<0.001). INTERPRETATION: CACPM significantly reduces the proportion of critically ill pediatric patients developing VAP compared with IMCPM. This preventive effect appears directly linked to improved target pressure compliance, suggesting that automated regulation could be a valuable addition to pediatric VAP prevention strategies. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT05918172.
引用
- Aşık A, Duyu M, Özdemir Dağhan SH, et al. Effectiveness of Continuous Automatic Endotracheal Cuff Pressure Monitoring in Preventing Ventilator-Associated Pneumonia in the Pediatric Intensive Care Unit: A Randomized Controlled Trial. Chest. 2026. PMID: 42858808. doi:10.1016/j.chest.2026.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。